Variable | Experimental (n = 109) | Control (n = 100) | P |
---|---|---|---|
Median age, years (SD) | 54.84 (13.44) | 59.08 (10.37) | |
Age group | |||
< 65 | 83 (55) | 68 (45) | 0.2172 |
≥ 65 | 26 (45) | 32 (55) | |
Sex | |||
Male | 69 (63) | 61 (61) | 0.7761 |
Female | 40 (37) | 39 (39) | |
Type of cancer | |||
Nasopharyngeal carcinoma | 7 (78) | 2 (22) | 0.3101 |
Lung cancer | 26 (44) | 33 (56) | |
Prostate cancer | 21 (50) | 21 (50) | |
Breast cancer | 25 (60) | 17 (40) | |
Oesophageal cancer | 16 (47) | 18 (53) | |
Gastric cancer | 14 (61) | 9 (39) | |
Line of therapy | |||
1 | 62 (57) | 52 (52) | 0.6755 |
2 | 28 (26) | 26 (26) | |
> 2 | 19 (17) | 22 (22) | |
ECOG PS | |||
0–1 | 93 (85) | 88 (88) | 0.5701 |
2 | 16 (15) | 12 (12) |